1McBrien K, Rabi DM, Campbell N, et al. Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med, 2012:1-8.
2Matsuo Y, Kuwabara M, Tanaka-Totoribe N, et al. The defective protein !evel of myosin light chain phosphatase (MLCP) in the isolated saphenous vein, as a vascular conduit in coronary artery bypass grafting (CABG), harvested from patients with diabetes mellitus (DM). Biochem Biophys Res Commun, 2011,412(2):323- 327.
3Henareh L, Agewall S. 2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus. Cardiovasc Diabetol, 2012,11(1):93.
4Ridker PM, Pradhan A, MacFadyen JG, et al. Cardiovascular benefits and diabetes risks of stat!n therapy in primary prevention: an analysis from the JUPITER trial. Lancet, 2012,380(9841):565- 571.
5Wang KL, Liu CJ, Chao TF, et al. Statins, Risk of diabetes, and implications on outcomes in the general population. J Am Coil Cardiol, 2012,60(14):1231-1238.
